A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD)
A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD)
Recruiting · NCT07748403 · Registry updated 2026-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD) | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Nutritional and Metabolic Diseases, Wilson disease, basal ganglia disorder, brain disorder, central nervous system disorder, hereditary disease, inborn errors of metabolism, inborn metal metabolism disorder, inherited neurodegenerative disorder, liver disorder, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease | Recruiting | Phase 1 / Phase 2 | 2026-10-01 | NCT07748403 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Prime Medicine, Inc. | 3 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| ARC Texas Liver Institute | San Antonio | United States | 1 |
| New Zealand Clinical Research (NZCR) | Grafton | New Zealand | 4 |
| Northwestern University Division of Gastroenterology and Hepatology | Chicago | United States | 2 |
| Yale New Haven Hospital | New Haven | United States | 52 |